Boston Scientific (BSX)

Boston Scientific (BSX) Income Statement


Boston Scientific Income Statement

Last quarter (Q2 2023), Boston Scientific's total revenue was $3.60B, an increase of 10.94% from the same quarter last year. In Q2, Boston Scientific's net income was $261.00M. See Boston Scientific’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 13.40B$ 12.68B$ 11.89B$ 9.91B$ 10.73B$ 9.82B
Cost of Revenue
$ 4.11B$ 4.00B$ 3.71B$ 3.51B$ 3.18B$ 2.88B
Gross Profit
$ 9.29B$ 8.68B$ 8.18B$ 6.40B$ 7.55B$ 6.94B
Operating Expense
$ 7.10B$ 6.65B$ 6.98B$ 5.72B$ 5.81B$ 5.28B
Operating Income
$ 2.22B$ 2.03B$ 1.82B$ 684.00M$ 1.74B$ 1.66B
Net Non Operating Interest Income Expense
$ -257.00M$ -460.00M$ -341.00M$ -358.00M$ -443.00M$ -238.00M
Other Income Expense
$ -123.00M$ -434.00M$ -62.00M$ -405.00M$ -612.00M$ -1.00M
Pretax Income
$ 1.51B$ 1.14B$ 1.08B$ -79.00M$ 687.00M$ 1.42B
Tax Provision
$ 599.00M$ 443.00M$ 36.00M$ 2.00M$ -4.01B$ -249.00M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 859.00M$ 642.00M$ 984.00M$ -115.00M$ 4.70B$ 1.67B
Basic EPS
$ 0.60$ 0.45$ 0.69$ -0.08$ 3.38$ 1.21
Diluted EPS
$ 0.60$ 0.45$ 0.69$ -0.08$ 3.33$ 1.19
Basic Average Shares
$ 5.75B$ 1.43B$ 1.42B$ 1.42B$ 1.39B$ 1.38B
Diluted Average Shares
$ 5.78B$ 1.44B$ 1.43B$ 1.42B$ 1.41B$ 1.40B
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
----$ 1.58-
Reported Normalized Diluted E P S
$ 0.88$ 1.71-$ 0.96$ 1.58$ 1.47
Rent Expense Supplemental
Total Expenses
$ 11.21B$ 10.65B$ 10.69B$ 9.23B$ 8.99B$ 8.16B
Net Income From Continuing And Discontinued Operation
$ 912.00M$ 698.00M$ 1.04B$ -82.00M$ 4.70B$ 1.67B
Normalized Income
$ 947.07M$ 953.40M-$ 218.76M$ 5.15B$ 1.66B
Interest Expense
$ 127.00M$ 470.00M-$ 361.00M$ 473.00M$ 241.00M
$ 1.77B$ 1.61B$ 1.42B$ 282.00M$ 1.16B$ 1.66B
$ 2.94B$ 2.75B$ 2.54B$ 1.41B$ 2.17B$ 2.56B
Currency in USD

Boston Scientific Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis